VXRT Vaxart Corp: Earnings per share for the trailing year

Official company branding of Vaxart Inc. (VXRT)

Vaxart, Inc. (VXRT) is developing unique medical solutions that are isolated from the global economy. The biotech's progress is based on clinical test results rather than GDP. The annual percentage change in earnings per share (ttm) illustrates this trend, where the 22.60 indicator determines the magnitude of the metric. Business success depends on biological factors, rendering the company independent of market fluctuations.

VXRT Vaxart Inc. Earnings per share for the last twelve months (02/11/2024 - 02/20/2024)

Vaxart, Inc. - analytical breakdowns and key metrics (VXRT)

- market price and analyst price targets:
Fundamental valuation:Vaxart Inc., VXRT
Flagship merchandise of Vaxart Corp

For Vaxart, Inc., a developer of innovative oral vaccines, the effectiveness of capitalizing on its patent moat is reflected in net profit dynamics. This metric measures the percentage change in earnings per share over the last 12 months relative to the same period last year. By analyzing the relative change in EPS YoY (TTM), an investor can discern the actual speed of development monetization. Growth in this metric confirms a reduction in operating expenses. A steady ascent on the chart signals the company's transition to a stage of sustainable profitability.

Competitor analysis for Vaxart, Inc.

Net earnings per share for the last four quarters Gilead GILD|Cidara Corp (CDTX) - Earnings per share for the last twelve months|Novavax, Inc. - Earnings per share for the trailing year|Net earnings per share for the last 12 months CVAC|Net earnings per share (EPS TTM) valneva.com|Net earnings per share for the last 12 months VIR (Vir Biotechnology)|Net earnings per share for the last four quarters SIGA Technologies Inc|Earnings per share for the last twelve months Emergent Bio EBS|Net earnings per share (EPS TTM) Atea Pharmaceuticals AVIR|IVVD - Earnings per share for the last twelve months|ENTA (Enanta Pharmaceuticals) - Earnings per share for the last 12 months|INO (Inovio) - Net earnings per share for the last 12 months|HLVX (HilleVax Inc) - Earnings per share for the last twelve months|KLRS (Kalaris Therapeutics Inc.) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months DYAI (Dyadic International)|Net earnings per share for the last 12 months NNVC (NanoViricides)|TLPH (Talphera, Inc.) - Earnings per share for the trailing year|Earnings per share for the last twelve months Cocrystal Pharma Inc COCP|Earnings per share for the trailing year TRAW|Dogwood Therapeutics Inc. - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Qualigen Corp|ALVR (AlloVir Bio) - Net earnings per share for the last 12 months|Net earnings per share for the last 12 months VBI Vaccines, Inc.|VIRI (virios.com) - Net earnings per share (EPS TTM)